Applied Materials and Medpace report strong quarterly growth

Applied Materials reported record third-quarter fiscal 2026 results, driven by strong demand for artificial intelligence. The company achieved a revenue of $9.115 billion, representing a 25 percent increase compared to the previous year. Adjusted earnings per share rose 41 percent to $3.50, while the adjusted gross margin climbed to 50.4 percent. The company's performance highlights new manufacturing cycles in the semiconductor industry to support AI workloads and data-intensive applications.

Medpace Holdings also reported strong growth for the second quarter of 2026. The clinical research organization achieved double-digit growth in both revenue and earnings. Despite investments in recruitment and additional capacity, the company maintained stable operating margins. Medpace reported a robust order backlog and increased bookings, supporting its revenue guidance for the full year 2026.